Alteration of bone strength is an adverse effect of antiepileptic drug treatment. We investigated the effects of zonisamide (ZNS) monotherapy on bone mineral density (BMD) and biomarkers of bone metabolism after 13 months of treatment in drug‐naive epileptic patients.

中文翻译：

---

唑尼沙胺单药治疗对初治癫痫患者骨骼健康的影响

骨强度的改变是抗癫痫药物治疗的副作用。我们研究了唑尼沙胺 (ZNS) 单药治疗对未经药物治疗的癫痫患者在治疗 13 个月后对骨矿物质密度 (BMD) 和骨代谢生物标志物的影响。